About Silicon Therapeutics
Silicon Therapeutics is a company based in Boston (United States) founded in 2016 by Lijun Sun was acquired by Roivant Sciences in February 2021. Silicon Therapeutics has raised $15 million across 2 funding rounds from investors including Roivant Sciences and Chengwei Capital. The company has 61 employees as of December 31, 2022. Silicon Therapeutics offers products and services including Immunovant, Priovant, and Pulmovant. Silicon Therapeutics operates in a competitive market with competitors including Insitro, Certara, HotSpot Therapeutics, Precision Neuroscience and CytoReason, among others.
- Headquarter Boston, United States
- Employees 61 as on 31 Dec, 2022
- Founders Lijun Sun
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Silicon Insite, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$15 M (USD)
in 2 rounds
-
Latest Funding Round
$15 M (USD), Series A
Oct 19, 2016
-
Investors
Roivant Sciences
& 1 more
-
Employee Count
61
as on Dec 31, 2022
-
Acquired by
Roivant Sciences
(Feb 26, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Silicon Therapeutics
Silicon Therapeutics offers a comprehensive portfolio of products and services, including Immunovant, Priovant, and Pulmovant.
Advances therapies for autoimmune diseases through targeted treatments.
Develops targeted therapies for severe autoimmune conditions.
Focuses on transforming treatments for pulmonary diseases.
People of Silicon Therapeutics
Unlock access to complete
Unlock access to complete
Leadership Team
24 people
Finance and Accounting
11 people
Board Team
9 people
Senior Team
9 people
Software Development Team
7 people
Advisor Team
6 people
Human Resources and Administration
6 people
Head Team
5 people
Unlock access to complete
Funding Insights of Silicon Therapeutics
Silicon Therapeutics has successfully raised a total of $15M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $15 million completed in October 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Silicon Therapeutics
Silicon Therapeutics has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Roivant Sciences and Chengwei Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Chengwei Capital is recognized as an early venture capital firm in China.
|
Locked | Locked | Locked | |
|
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
|
Locked | Locked | Locked |
Investor details for Silicon Therapeutics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Silicon Therapeutics
Investment portfolio details for Silicon Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Silicon Therapeutics
Detailed financials for Silicon Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Silicon Therapeutics Comparisons
Peer comparison for Silicon Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Silicon Therapeutics
Silicon Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insitro, Certara, HotSpot Therapeutics, Precision Neuroscience and CytoReason, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
An AI-enabled platform is developed for infectious disease treatment.
|
|
| Locked | Locked | Locked |
Provider of a platform for in silico drug discovery and consulting services
|
|
| Locked | Locked | Locked |
Developer of a platform for protein function analysis
|
|
| Locked | Locked | Locked |
Brain-computer interfaces developed for medical treatment and drug development.
|
|
| Locked | Locked | Locked |
Immune system-based drugs are discovered via biological data analytics.
|
|
| Locked | Locked | Locked |
Synthetic biology tools are developed via genetic code recoding techniques.
|
Detailed competitors of Silicon Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Silicon Therapeutics
Complete news archive for Silicon Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Silicon Therapeutics
Silicon Therapeutics was founded in 2016.
Silicon Therapeutics is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Silicon Therapeutics is a funded company, having raised a total of $15M across 2 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Silicon Therapeutics is 61.
Silicon Therapeutics was founded in 2016 in Boston, United States, within the biotechnology sector. In silico models of human drug targets are constructed to design novel therapeutics. The proprietary INSITE platform is utilized for targeted engineering efforts. Operations focus on computational drug discovery, with applications in pharmaceutical development across the region.
Silicon Therapeutics's top competitors include Insitro, HotSpot Therapeutics and Precision Neuroscience.
Silicon Therapeutics offers Immunovant, Priovant, and Pulmovant.
Silicon Therapeutics has 2 investors. Key investors include Roivant Sciences, and Chengwei Capital.